메뉴 건너뛰기




Volumn 39, Issue 9, 2014, Pages 984-991

Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: A nationwide study of 9883 patients

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

EID: 84898602344     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12693     Document Type: Article
Times cited : (83)

References (42)
  • 1
    • 76549218484 scopus 로고
    • Chronic peptic ulcer of the oesophagus and oesophagitis
    • Barrett NR,. Chronic peptic ulcer of the oesophagus and oesophagitis. Br J Surg 1950; 38: 175-82.
    • (1950) Br J Surg , vol.38 , pp. 175-182
    • Barrett, N.R.1
  • 2
    • 75149134769 scopus 로고    scopus 로고
    • Barrett's oesophagus and oesophageal adenocarcinoma: Time for a new synthesis
    • Reid BJ, Li X, Galipeau PC, et al,. Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer 2010; 10: 87-101.
    • (2010) Nat Rev Cancer , vol.10 , pp. 87-101
    • Reid, B.J.1    Li, X.2    Galipeau, P.C.3
  • 3
    • 63949087969 scopus 로고    scopus 로고
    • Prevalence of complicated gastroesophageal reflux disease and Barrett's esophagus among racial groups in a multi-center consortium
    • Wang A, Mattek NC, Holub JL, et al,. Prevalence of complicated gastroesophageal reflux disease and Barrett's esophagus among racial groups in a multi-center consortium. Dig Dis Sci 2009; 54: 964-71.
    • (2009) Dig Dis Sci , vol.54 , pp. 964-971
    • Wang, A.1    Mattek, N.C.2    Holub, J.L.3
  • 4
    • 0030040665 scopus 로고    scopus 로고
    • The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett
    • Spechler SJ, Goyal RK,. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996; 110: 614-21. (Pubitemid 26043897)
    • (1996) Gastroenterology , vol.110 , Issue.2 , pp. 614-621
    • Spechler, S.J.1    Goyal, R.K.2
  • 6
    • 0016771074 scopus 로고
    • Columnar-lined lower esophagus - Acquired lesion with malignant predisposition - Report on 140 cases of Barretts esophagus with 12 adenocarcinomas
    • Naef AP, Savary M, Ozzello L,. Columnar-lined lower esophagus-acquired lesion with malignant predisposition-report on 140 cases of Barretts esophagus with 12 adenocarcinomas. J Thorac Cardiov Sur 1975; 70: 826-35.
    • (1975) J Thorac Cardiov sur , vol.70 , pp. 826-835
    • Naef, A.P.1    Savary, M.2    Ozzello, L.3
  • 7
    • 77349099667 scopus 로고    scopus 로고
    • Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: A systematic review and meta-analysis
    • Sikkema M, de Jonge PJF, Steyerberg EW, et al,. Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2010; 8: 235-44.
    • (2010) Clin Gastroenterol Hepatol , vol.8 , pp. 235-244
    • Sikkema, M.1    De Jonge, P.J.F.2    Steyerberg, E.W.3
  • 8
    • 80054010196 scopus 로고    scopus 로고
    • Incidence of adenocarcinoma among patients with Barrett's esophagus
    • Hvid-Jensen F, Pedersen L, Drewes AM, et al,. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011; 365: 1375-83.
    • (2011) N Engl J Med , vol.365 , pp. 1375-1383
    • Hvid-Jensen, F.1    Pedersen, L.2    Drewes, A.M.3
  • 9
    • 79960249713 scopus 로고    scopus 로고
    • Risk of malignant progression in Barrett's esophagus patients: Results from a large population-based study
    • Bhat S, Coleman HG, Yousef F, et al,. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J Natl Cancer Inst 2011; 103: 1-9.
    • (2011) J Natl Cancer Inst , vol.103 , pp. 1-9
    • Bhat, S.1    Coleman, H.G.2    Yousef, F.3
  • 10
    • 0036161377 scopus 로고    scopus 로고
    • Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus
    • Souza RF, Shewmake K, Terada LS, et al,. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology 2002; 122: 299-307. (Pubitemid 34126346)
    • (2002) Gastroenterology , vol.122 , Issue.2 , pp. 299-307
    • Souza, R.F.1    Shewmake, K.2    Terada, L.S.3    Spechler, S.J.4
  • 11
    • 0035119855 scopus 로고    scopus 로고
    • Review article: Barrett's oesophagus, dysplasia and pharmacologic acid suppression
    • DOI 10.1046/j.1365-2036.2001.00939.x
    • Fitzgerald RC, Lascar R, Triadafilopoulos G,. Review article: Barrett's oesophagus, dysplasia and pharmacologic acid suppression. Aliment Pharmacol Ther 2001; 15: 269-76. (Pubitemid 32187550)
    • (2001) Alimentary Pharmacology and Therapeutics , vol.15 , Issue.3 , pp. 269-276
    • Fitzgerald, R.C.1    Lascar, R.2    Triadafilopoulos, G.3
  • 12
    • 66149130687 scopus 로고    scopus 로고
    • Medical treatment of Barrett's esophagus: Can it prevent cancer?
    • Sampliner RE,. Medical treatment of Barrett's esophagus: can it prevent cancer? Surg Oncol Clin N Am 2009; 18: 503-8.
    • (2009) Surg Oncol Clin N Am , vol.18 , pp. 503-508
    • Sampliner, R.E.1
  • 14
  • 15
    • 33644781586 scopus 로고    scopus 로고
    • Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: Observations on regression and cancer incidence
    • DOI 10.1111/j.1365-2036.2006.02825.x
    • Cooper BT, Chapman W, Neumann CS, et al,. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. Aliment Pharmacol Ther 2006; 23: 727-33. (Pubitemid 43344591)
    • (2006) Alimentary Pharmacology and Therapeutics , vol.23 , Issue.6 , pp. 727-733
    • Cooper, B.T.1    Chapman, W.2    Neumann, C.S.3    Gearty, J.C.4
  • 16
    • 70849132813 scopus 로고    scopus 로고
    • Medication usage and the risk of neoplasia in patients with Barrett's esophagus
    • Nguyen DM, El-Serag HB, Henderson L, et al,. Medication usage and the risk of neoplasia in patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2009; 7: 1299-304.
    • (2009) Clin Gastroenterol Hepatol , vol.7 , pp. 1299-1304
    • Nguyen, D.M.1    El-Serag, H.B.2    Henderson, L.3
  • 17
    • 33750352352 scopus 로고    scopus 로고
    • Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: A nested case control study in the UK
    • DOI 10.1136/gut.2005.086579
    • Rodriguez LAG, Lagergren J, Lindblad M,. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut 2006; 55: 1538-44. (Pubitemid 44629198)
    • (2006) Gut , vol.55 , Issue.11 , pp. 1538-1544
    • Garcia Rodriguez, L.A.1    Lagergren, J.2    Lindblad, M.3
  • 18
    • 38149050433 scopus 로고    scopus 로고
    • Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus
    • Hillman LC, Chiragakis L, Shadbolt B, et al,. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus. Aliment Pharmacol Ther 2008; 27: 321-6.
    • (2008) Aliment Pharmacol Ther , vol.27 , pp. 321-326
    • Hillman, L.C.1    Chiragakis, L.2    Shadbolt, B.3
  • 19
    • 84875365855 scopus 로고    scopus 로고
    • Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus
    • Kastelein F, Spaander MC, Steyerberg EW, et al,. Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2013; 11: 382-8.
    • (2013) Clin Gastroenterol Hepatol , vol.11 , pp. 382-388
    • Kastelein, F.1    Spaander, M.C.2    Steyerberg, E.W.3
  • 21
    • 77953448707 scopus 로고    scopus 로고
    • Existing data sources for clinical epidemiology: The Danish National Pathology Registry and Data Bank
    • Erichsen R,. Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank. Clini Epidemiol 2010; 2: 51-6.
    • (2010) Clini Epidemiol , vol.2 , pp. 51-56
    • Erichsen, R.1
  • 22
    • 74549129623 scopus 로고    scopus 로고
    • W. ATC/DDD classification
    • World Health Organization.
    • World Health Organization. W. ATC/DDD classification. WHO Drug Information 2001; 15: 84-8.
    • (2001) WHO Drug Information , vol.15 , pp. 84-88
  • 23
    • 34548566069 scopus 로고    scopus 로고
    • Proton Pump Inhibitor Use and Risk of Colorectal Cancer: A Population-Based, Case-Control Study
    • DOI 10.1053/j.gastro.2007.06.014, PII S0016508507011559
    • Robertson DJ, Larsson H, Friis S, et al,. Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study. Gastroenterology 2007; 133: 755-60. (Pubitemid 47385871)
    • (2007) Gastroenterology , vol.133 , Issue.3 , pp. 755-760
    • Robertson, D.J.1    Larsson, H.2    Friis, S.3    Pedersen, L.4    Baron, J.A.5    Sorensen, H.T.6
  • 24
    • 79952288119 scopus 로고    scopus 로고
    • American Gastroenterological Association medical position statement on the management of Barrett's esophagus
    • Spechler SJ, Sharma P, Souza RF, et al,. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology 2011; 140: 1084-91.
    • (2011) Gastroenterology , vol.140 , pp. 1084-1091
    • Spechler, S.J.1    Sharma, P.2    Souza, R.F.3
  • 25
    • 84889681189 scopus 로고    scopus 로고
    • British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus
    • Fitzgerald RC, di Pietro M, Ragunath K, et al,. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut 2014; 63: 7-42.
    • (2014) Gut , vol.63 , pp. 7-42
    • Fitzgerald, R.C.1    Di Pietro, M.2    Ragunath, K.3
  • 26
    • 77955914922 scopus 로고    scopus 로고
    • Bile acids are multifunctional modulators of the Barrett's carcinogenesis
    • Burnat G, Majka J, Konturek PC,. Bile acids are multifunctional modulators of the Barrett's carcinogenesis. J Physiol Pharmacol 2010; 61: 185-92.
    • (2010) J Physiol Pharmacol , vol.61 , pp. 185-192
    • Burnat, G.1    Majka, J.2    Konturek, P.C.3
  • 27
    • 79959378981 scopus 로고    scopus 로고
    • Systematic review: The role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia
    • McQuaid KR, Laine L, Fennerty MB, et al,. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment Pharmacol Ther 2011; 34: 146-65.
    • (2011) Aliment Pharmacol Ther , vol.34 , pp. 146-165
    • McQuaid, K.R.1    Laine, L.2    Fennerty, M.B.3
  • 28
    • 84857053733 scopus 로고    scopus 로고
    • Acid suppression increases rates of Barrett's esophagus and esophageal injury in the presence of duodenal reflux
    • Nasr AO, Dillon MF, Conlon S, et al,. Acid suppression increases rates of Barrett's esophagus and esophageal injury in the presence of duodenal reflux. Surgery 2012; 151: 382-90.
    • (2012) Surgery , vol.151 , pp. 382-390
    • Nasr, A.O.1    Dillon, M.F.2    Conlon, S.3
  • 29
    • 84861345403 scopus 로고    scopus 로고
    • Bile exposure inhibits expression of squamous differentiation genes in human esophageal epithelial cells
    • Reveiller M, Ghatak S, Toia L, et al,. Bile exposure inhibits expression of squamous differentiation genes in human esophageal epithelial cells. Ann Surg 2012; 255: 1113-20.
    • (2012) Ann Surg , vol.255 , pp. 1113-1120
    • Reveiller, M.1    Ghatak, S.2    Toia, L.3
  • 30
    • 79551632075 scopus 로고    scopus 로고
    • Effect of proton-pump inhibitor therapy on serum chromogranin a level
    • Pregun I, Herszenyi L, Juhasz M, et al,. Effect of proton-pump inhibitor therapy on serum chromogranin a level. Digestion 2011; 84: 22-8.
    • (2011) Digestion , vol.84 , pp. 22-28
    • Pregun, I.1    Herszenyi, L.2    Juhasz, M.3
  • 31
    • 67449132488 scopus 로고    scopus 로고
    • Glycine-extended gastrin inhibits apoptosis in Barrett's oesophageal and oesophageal adenocarcinoma cells through JAK2/STAT3 activation
    • Beales IL, Ogunwobi OO,. Glycine-extended gastrin inhibits apoptosis in Barrett's oesophageal and oesophageal adenocarcinoma cells through JAK2/STAT3 activation. J Mol Endocrinol 2009; 42: 305-18.
    • (2009) J Mol Endocrinol , vol.42 , pp. 305-318
    • Beales, I.L.1    Ogunwobi, O.O.2
  • 32
    • 56049120292 scopus 로고    scopus 로고
    • Glycine-extended gastrin stimulates proliferation via JAK2- and Akt-dependent NF-kappaB activation in Barrett's oesophageal adenocarcinoma cells
    • Ogunwobi OO, Beales IL,. Glycine-extended gastrin stimulates proliferation via JAK2- and Akt-dependent NF-kappaB activation in Barrett's oesophageal adenocarcinoma cells. Mol Cell Endocrinol 2008; 296: 94-102.
    • (2008) Mol Cell Endocrinol , vol.296 , pp. 94-102
    • Ogunwobi, O.O.1    Beales, I.L.2
  • 33
    • 77149170365 scopus 로고    scopus 로고
    • Long-term proton pump induced hypergastrinaemia does induce lineage-specific restitution but not clonal expansion in benign Barrett's oesophagus in vivo
    • Obszynska JA, Atherfold PA, Nanji M, et al,. Long-term proton pump induced hypergastrinaemia does induce lineage-specific restitution but not clonal expansion in benign Barrett's oesophagus in vivo. Gut 2010; 59: 156-63.
    • (2010) Gut , vol.59 , pp. 156-163
    • Obszynska, J.A.1    Atherfold, P.A.2    Nanji, M.3
  • 34
    • 77951977553 scopus 로고    scopus 로고
    • Elevated serum gastrin is associated with a history of advanced neoplasia in Barrett's esophagus
    • Wang JS, Varro A, Lightdale CJ, et al,. Elevated serum gastrin is associated with a history of advanced neoplasia in Barrett's esophagus. Am J Gastroenterol 2010; 105: 1039-45.
    • (2010) Am J Gastroenterol , vol.105 , pp. 1039-1045
    • Wang, J.S.1    Varro, A.2    Lightdale, C.J.3
  • 35
    • 79953316196 scopus 로고    scopus 로고
    • Correlation between serum gastrin and cellular proliferation in Barrett's esophagus
    • Green DA, Mlynarczyk CM, Vaccaro BJ, et al,. Correlation between serum gastrin and cellular proliferation in Barrett's esophagus. Therap Adv Gastroenterol 2011; 4: 89-94.
    • (2011) Therap Adv Gastroenterol , vol.4 , pp. 89-94
    • Green, D.A.1    Mlynarczyk, C.M.2    Vaccaro, B.J.3
  • 37
    • 0037320854 scopus 로고    scopus 로고
    • Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: A population-based case-control study
    • DOI 10.1161/01.STR.0000054057.11892.5B
    • Johnsen SP, Pedersen L, Friis S, et al,. Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: a population-based case-control study. Stroke 2003; 34: 387-91. (Pubitemid 36206335)
    • (2003) Stroke , vol.34 , Issue.2 , pp. 387-391
    • Johnsen, S.P.1    Pedersen, L.2    Friis, So.3    Blot, W.J.4    McLaughlin, J.K.5    Olsen, Jo.H.6    Sorensen, H.T.7
  • 38
    • 0033580405 scopus 로고    scopus 로고
    • Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
    • DOI 10.1056/NEJM199903183401101
    • Lagergren J, Bergstrom R, Lindgren A, et al,. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31. (Pubitemid 29142625)
    • (1999) New England Journal of Medicine , vol.340 , Issue.11 , pp. 825-831
    • Lagergren, J.1    Bergstrom, R.2    Lindgren, A.3    Nyren, O.4
  • 39
    • 79955938731 scopus 로고    scopus 로고
    • Proximal and distal esophageal sensitivity is decreased in patients with Barrett's esophagus
    • Krarup AL, Olesen SS, Funch-Jensen P, et al,. Proximal and distal esophageal sensitivity is decreased in patients with Barrett's esophagus. World J Gastroenterol 2011; 17: 514-21.
    • (2011) World J Gastroenterol , vol.17 , pp. 514-521
    • Krarup, A.L.1    Olesen, S.S.2    Funch-Jensen, P.3
  • 40
    • 77957114279 scopus 로고    scopus 로고
    • What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis
    • e2.
    • Ford AC, Marwaha A, Lim A, et al,. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis Clin Gastroenterol Hepatol 2010; 8: 830-7.e2.
    • (2010) Clin Gastroenterol Hepatol , vol.8 , pp. 830-837
    • Ford, A.C.1    Marwaha, A.2    Lim, A.3
  • 41
    • 77949262976 scopus 로고    scopus 로고
    • Dyspeptic symptoms and endoscopic findings in the community: The Loiano-Monghidoro Study
    • Zagari RM, Law GR, Fuccio L, et al,. Dyspeptic symptoms and endoscopic findings in the community: the Loiano-Monghidoro Study. Am J Gastroenterol 2009; 105: 565-71.
    • (2009) Am J Gastroenterol , vol.105 , pp. 565-571
    • Zagari, R.M.1    Law, G.R.2    Fuccio, L.3
  • 42
    • 33745195704 scopus 로고    scopus 로고
    • Gastro-oesophageal reflux disease
    • Moayyedi P, Talley NJ,. Gastro-oesophageal reflux disease. Lancet 2006; 367: 2086-100.
    • (2006) Lancet , vol.367 , pp. 2086-2100
    • Moayyedi, P.1    Talley, N.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.